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Abstract. In machine learning terms DNA (gene) chip data is unusual
in having thousands of attributes (the gene expression values) but few
(< 100) records (the patients). A GP based method for both feature
selection and generating simple models based on a few genes is demon-
strated on cancer data.
1 Introduction
The problem of over tting is a dominant concern with machine learning ap-
proaches to DNA chip data. These medical data are characterised by class im-
balance, non-linear response, high noise, large numbers of attributes and few
examples. Last year [Pomeroy et al., 2002] published DNA chip data for 60
cancer patients. Their attempts to model the data using unsupervised learning
techniques (self organising maps) were unsuccessful at predicting patient sur-
vival (page 441) however they claim statistically signicant success using near-
est neighbour and other supervised learning techniques. [Li et al., 2001] obtained
good results using three nearest neighbours after selecting genes with a multi-
run evolutionary approach on similarly sized DNA expression data. ([Valafar,
2002] surveys both supervised and unsupervised data mining techniques used
with microarray data.)
Genetic programming (GP) has been used with DNA chip data previously.
For example [Gilbert et al., 2000] used it with time sequences of expression levels
in yeast to ascribe functions to genes. However here we consider much smaller
static expression data sets to classify, either the patient as a whole or specic
tissues (e.g. cancer tissues). Classications might in future suggest particular
treatments. Also identication of predictive genes may aid understanding of
causes and hence treatments of diseases. While [Moore et al., 2002] showed GP
can be used to t DNA expression data, we show it can be used to nd very
simple models, with consequently little danger of over tting. There follows an
experiment which shows linear discrimination using two genes found by GP (from
a total of 7129) gives similar performance to that given in [Pomeroy et al., 2002].
12 Cancer DNA chip data
[Pomeroy et al., 2002]'s \Gene Expression-Based Classication and Outcome
Prediction of Central Nervous System Embryonal Tumors" data was copied from
http://www-genome.wi.mit.edu/mpr/publications/projects/CNS/Pomeroy
et al 0G04850 11142001 datasets.zip. Gene descriptors and patient
identication were removed from Dataset C MD outcome.gct and Dataset C
MD outcome.xls, which were then merged and transposed. There are 7129 signed
integer gene expression values for each of the 60 patients, of whom 39 survived.
3 Leave One Out Cross Validation
n-fold cross validation allows one to estimate how well a learning technique will
perform on unseen data without reserving a sizeable volume of data for testing.
The data is divided into (say n = 5) equal numbers of records, known as folds.
The learning system is trained on all records except one fold. Its performance
on the remaining records is measured. Then the same system is trained again
but this time leaving out another fold. The performance of the learning system
is estimated by taking the mean of the (ve) performance measurements. As
always, care must be taken that their is no cross contamination which might
allow knowledge about patterns in the test data (i.e. the test folds) to leak into
the training process.
Since there are only a very few training examples, we go to the extreme
of having as many folds as their are records (60). I.e. the GP is trained sixty
times using 59 patient records. Leave one out gives an almost unbiased estimate
but its variance may be high [Kohavi, 1995]. Each time the performance of the
evolved model is measured by seeing if it can predict the survival of the remaining
patient. Because genetic programming is a stochastic process, the GP is run ten
times (cf. [Carvalho and Freitas, 2003]), making a total of 600 runs for each stage
in the experiment.
4 Genetic Programming
The individuals in the GP population consist of ve trees. At crossover one
of the ve is chosen and size fair crossover [Langdon, 2000] occurs only be-
tween that tree in rst and second parents. The remaining four trees are copied
unchanged from the rst parent [Langdon, 1998]. The GP's prediction is posi-
tive if the sum of the oating point values returned by the ve trees is greater
than or equal to zero. While, in this work, having multiple trees, does not di-
rectly increase the power of the representation, it may help by making it easier
for dierent parts of the individuals to evolve to specialise in solving dier-
ent parts of a problem. [Soule, 1999], [Rodriguez-Vazquez and Oliver-Morales,
2003] and ourselves [Langdon and Buxton, 2001a; Langdon and Buxton, 2001b;
Langdon et al., 2001] report some success with it. Gene expression values are
represented as oating point numbers. We retained our use of area under the
(convex hull of) the receiver operating characteristics (ROC) curve as the tness
2measure [Langdon and Buxton, 2001c]. But for speed and simplicity only a single
threshold point on the curve was used. This collapses tness to 1
2(TP+(1 FP)),
where TP=true positive rate and FP=false positive rate. I.e. the mean of the
accuracy on the positive examples and the accuracy on the negative. See Table 1
for other GP parameters.
Table 1. GP DNA Chip gene mining
Objective: Find a simple rule predicting patient survival from gene expression data
Function set: Max Min MaxA MinA MUL ADD DIV SUB IFLTE
Terminal set: DNA chip expression values.
Fitness:
1
2 fraction of survivors predicted +
1
2 fraction treatment failures correctly
predicted
Selection: generational (non elitist), tournament size 7
Wrapper: < 0 ) patient survival is predicted
Pop Size: 500
Program size: up to 1000. In two gene runs, all programs were size 5 or 9.
Initial pop: Each individual comprises ve trees each created by ramped half-and-
half (2:6). Each initial tree limited to 300
Parameters: 50% size fair crossover, crossover fragments  30 [Langdon, 2000]
50% mutation (point 22.5%, constants 22.5%, shrink 2.5% subtree 2.5%)
Termination: generation 50
5 Mining Genes from Genetic Programming
The rst group of 600 GP runs produced 600 best of run models. Together they
contained 6970 of the 7129 DNA chip attributes. Some attributes were used
much more than others. We selected the 404 genes which occurred in ten or
more best of run individuals ([Moore et al., 2002] used nine as a cut point in
similar data). We re-ran the GP a second 600 times.
All the 404 genes were used by at least one of the 600 best of run individuals.
However again the distribution of genes across models was highly non uniform
with only two genes occurring in more than 100 models, see Figure 1. Genes
U08998 at and U41737 at occurred in 182 and 193 best of run models. The
rst gene (TAR RNA binding protein (TRBP) mRNA, U08998 at) is known to
promote the formation or development of cancerous tumours [Benkirane et al.,
1997] but [Pomeroy et al., 2002, supplemental] says it is not amongst the top
marker genes selected by signal-to-noise (mean) ratio (it is in the middle of the
top 200). The second gene (Pancreatic beta cell growth factor (INGAP) mRNA,
U41737 at) is not amongst [Pomeroy et al., 2002, supplemental]'s top 200 but
may be involved in the onset of diabetes [Rafaelo et al., 1997]. [Pomeroy et al.,
2002] heavily thresholded the data for these two genes (cf. Figure 2) which may
explain why they were not identied. However their consistently low expression
values do raise questions about data pre-processing and the practicality of using
either gene in diagnostics tests.
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Fig.1. Number of best of run GP models in 600 second stage GP runs which
included each of the 404 genes selected by the rst stage from the total of 7129
genes. Genes more than 4 from mean are labelled.
We felt that applying the full power of genetic programming to noisy data
was liable to generate overly complex models. Instead in a nal 600 runs we
severely limited the GP's expression and learning abilities. The model size and
function set were both limited so models could only contain either no functions
at all or a single IF statement and only the initial random generation was used.
The leave one out estimate of the accuracy of the random two gene models
is 68%. [Pomeroy et al., 2002] claims 47/60 (78% accuracy) with a k=5 nearest
neighbour classier using 8 genes. While their classiers may be better, they are
more complex. Also, with only 60 cases, we cannot show the dierence between
68% and 78% is signicant ( = 6%).
Three quarters of all cases (147 of 192) where the random models made
incorrect predictions can be traced to 15 cases which are signicantly (p < 0:01)
harder than the overall leave one out estimate of accuracy (68%) would suggest.
These are shown with solid markings in Figure 2. In 39 of the remaining 45 cases
the random two gene models made the correct prediction more often than not.
Figure 2 shows the patient data. It is clear that the cases which prove hard
on the leave one out two gene trials are hard because they lie within clusters of
patients with the opposite outcome. Figure 2 also shows the decision boundaries
of two typical random two gene models. Over the range of the data, one is linear
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Fig.2. Expression of two genes from 7129 used to predict outcome of cancer
treatment [Pomeroy et al., 2002]. The piecewise linear decision boundary is the
best of 500 random programs using just these two genes (from the rst of ten runs
leaving out patient record 6). Solid shapes indicate cases which are signicantly
harder to predict. The linear boundary produced when leaving out a dierent
record (37) is shown dotted. It predicts survival if 2U08998 at+U41737 at <
 43 and makes only one more error. Dashed rectangle indicates threshold (20)
used by [Pomeroy et al., 2002], only nine patient records are not aected by such
thresholding.
and the other is piecewise linear. While there many possible views of the data,
the intermixing of survivors (squares) and non-survivors (triangles) in Figure 2
suggests that gene expression data cannot be 100% predictive and that there are
other important factors.
6 Discussion
In general optimal selection of features (genes in our case) requires exponential
eort, even for simple xed interaction between features. Since optimal selection
is not feasible, heuristics are used. Traditionally either forward or backward
feature selection are used. They use a xed interaction rule between features
(typically linear) and sequentially process features one at a time. Either all
features are included and the set is trimmed one feature at a time or no features
are initialy included, then the most informative is added, followed by the next
5(given those already selected) and so on. There is no scope for going back and
re-considering features that have already been discarded (or selected).
Genetic programming is an alternative heuristic. Instead of a xed combina-
tion rule, it allows almost any means of combining a number of features. (GP is
also free to select the number of features.) At any one time, there isn't a single
set of selected features, but instead a population of individuals using features.
Evolution is free to add/remove multiple features (rather than one) and can
re-consider previous selection/removal decisions as new combinations are tried.
We have rerun the experiments with dierent settings. Naturally in detail
each run is very dierent. While, with ten replications of each validation fold,
no signicant dierence in the two main genes was found, a dierent GP study
might give dierent models (of similar performance).
It is clear from this, and similar, data sets that there are many ways to make
predictions from non-linear combinations of subsets of genes whose accuracies
are not signicantly dierent. GP is a general powerful, noise tolerant, way of
nding them, which can yield easily interpretable functions, rather than black
boxes.
7 Conclusions
The enormous width of DNA gene chip data makes over tting an ever present
danger, particularly with powerful machine learning approaches. Genetic pro-
gramming, in combination with leave one out cross validation and a principled
objective function (which takes into account the class imbalance often found in
Biological data sources) has been used to evolve many non-linear functions of
gene expression values. The goal has been to whittle down the thousands of data
attributes (gene expression measurements) into a few predictive ones.
We were surprised to nd only one or two genes are needed to make predic-
tions and by the simplicity of the models found by genetic programming. These
results strongly suggest deterministic algorithms which only allow linear inter-
action but which are able to deal eectively with thousands of data attributes
will also do well on this dataset. However the low data values given for the ex-
pression of the two genes raise questions about the pre-processing required when
performing gene chip experiments. Other experiments (also on treatment out-
come in animal and Human studies) conrm GP as a potentially valuable gene
selection technique when extracting knowledge from DNA chip data.
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